Eudaimonia Asset Management »

Zentalis Pharmaceuticals shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $615k 127k 4.85

More positions owned by Eudaimonia Asset Management

Blackrock Funds - Equities ETF (SMIN)
Vicor Corp Common Stock (VICR)
Bloom Energy Corp Common Stock (BE)
Guardant Health Common Stock (GH)
BrightSpring Health Services Common Stock (BTSG)
CECO Environmental Corp Common Stock (CECO)
SiTime Corp Common Stock (SITM)
Sphere Entertainment Common Stock (SPHR)
Viavi Solutions Common Stock (VIAV)
Semtech Corp Common Stock (SMTC)
DigitalOcean Holdings Common Stock (DOCN)
Modine Manufacturing Common Stock (MOD)
Revolution Medicines Common Stock (RVMD)
Kulicke & Soffa Industries Common Stock (KLIC)
MACOM Technology Solutions Holdings Common Stock (MTSI)

View all positions for Eudaimonia Asset Management

Top funds holding Zentalis Pharmaceuticals

Squadron Capital Management
5AM Venture Management
BlackRock
Two Sigma Investments
Vanguard Capital Management
Acadian Asset Management
Citadel Advisors
Renaissance Technologies
Opaleye Management
OrbiMed Advisors
Decheng Capital
Geode Capital Management
Bank of America Corporation
PRIMECAP Management Company
Pfizer

View all funds holding Zentalis Pharmaceuticals